• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戊二醛反应的L-古洛糖酸内酯氧化酶免疫沉淀物适合于给豚鼠给药。

Glutaraldehyde-reacted immunoprecipitates of L-gulonolactone oxidase are suitable for administration to guinea pigs.

作者信息

Sato P H, Walton D M

出版信息

Arch Biochem Biophys. 1983 Mar;221(2):543-7. doi: 10.1016/0003-9861(83)90173-x.

DOI:10.1016/0003-9861(83)90173-x
PMID:6404221
Abstract

The potential pharmacologic use of enzymes has long been considered. Practical applications, however, have been limited by the toxicity and allergic response to administered foreign proteins. A simple in vitro modification that allows the intraperitoneal administration of large doses of L-gulonolactone oxidase to guinea pigs is described. The enzyme is precipitated by guinea pig antisera and reacted with glutaraldehyde (0.125%). The product is comparatively nontoxic in guinea pigs. Administration of this enzyme enables guinea pigs to synthesize ascorbic acid. Success of this approach may depend on reinforcement by the bifunctional reagent of the enzyme-antibody complex.

摘要

酶在药理学上的潜在用途早已受到关注。然而,实际应用一直受到所注入外源蛋白的毒性和过敏反应的限制。本文描述了一种简单的体外修饰方法,该方法可使豚鼠腹腔注射大剂量的L-古洛糖酸内酯氧化酶。该酶用豚鼠抗血清沉淀,然后与戊二醛(0.125%)反应。所得产物在豚鼠中相对无毒。给予这种酶能使豚鼠合成抗坏血酸。这种方法的成功可能取决于双功能试剂对酶-抗体复合物的强化作用。

相似文献

1
Glutaraldehyde-reacted immunoprecipitates of L-gulonolactone oxidase are suitable for administration to guinea pigs.戊二醛反应的L-古洛糖酸内酯氧化酶免疫沉淀物适合于给豚鼠给药。
Arch Biochem Biophys. 1983 Mar;221(2):543-7. doi: 10.1016/0003-9861(83)90173-x.
2
A protocol for the successful long-term enzyme replacement therapy of scurvy in guinea pigs.豚鼠坏血病成功长期酶替代疗法的方案。
J Inherit Metab Dis. 1988;11(4):387-96. doi: 10.1007/BF01800427.
3
Heterologous immunoprecipitates also have potential for therapeutic use.
Biotechnol Appl Biochem. 1987 Feb;9(1):1-11.
4
Intravascularly administered crosslinked immunoprecipitates of gulonolactone oxidase are toxic and rapidly cleared from the circulation.血管内注射的古洛糖酸内酯氧化酶交联免疫沉淀物具有毒性,并能迅速从循环中清除。
Biotechnol Appl Biochem. 1986 Apr-Jun;8(2-3):182-9.
5
Feasibility of using an isolated intestinal segment as an artificial organ for enzyme replacement therapy.使用孤立肠段作为人工器官进行酶替代疗法的可行性。
Biomater Med Devices Artif Organs. 1982;10(1):55-62. doi: 10.3109/10731198209118771.
6
Treatment of a metabolic disease, scurvy, by administration of the missing enzyme.
Biochem Med Metab Biol. 1986 Feb;35(1):59-64. doi: 10.1016/0885-4505(86)90058-7.
7
Adaptability of an enzyme replacement therapy to other enzymes with potential therapeutic applications.酶替代疗法对其他具有潜在治疗应用的酶的适应性。
J Appl Biochem. 1985 Aug-Oct;7(4-5):323-31.
8
Synthesis of ascorbic acid in guinea pigs by an implanted dialysis bag containing L-gulonolactone oxidase.
Mol Pharmacol. 1980 Sep;18(2):326-30.
9
Guinea pigs can synthesize ascorbic acid when injected with L-gulonolactone oxidase.
Nutr Rev. 1982 Oct;40(10):310-1. doi: 10.1111/j.1753-4887.1982.tb05238.x.
10
Can some people synthesize ascorbic acid?
Am J Clin Nutr. 1981 Feb;34(2):297-8. doi: 10.1093/ajcn/34.2.297.